MedPath

Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH
Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection.

In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock .

Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics .

In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions
Anaphylaxis, Angioneurotic Edema, Bleeding, Bronchospasm, Complete Heart Block, Hypotension, Idiopathic Anaphylaxis, Laryngotracheobronchitis, Mild Intermittent Asthma, Nasal Congestion, Open Angle Glaucoma (OAG), Respiratory Distress, Severe Asthma, Syncope, Type I Hypersensitivity, Urticaria, Uterine Contractions, Ventricular Fibrillation, Resuscitation in cardiac arrest following anesthetic accidents, Severe hypersensitivity reactions, Unresponsive Asystole, Unresponsive Bradycardia

The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow

Phase 3
Recruiting
Conditions
ST Segment Elevation Myocardial Infarction (STEMI)
No Reflow Phenomenon
Interventions
First Posted Date
2025-02-26
Last Posted Date
2025-03-11
Lead Sponsor
Ain Shams University
Target Recruit Count
1000
Registration Number
NCT06847568
Locations
🇪🇬

Faculty of medicine Ain Shams Univesity, Cairo, Egypt

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Phase 4
Not yet recruiting
Conditions
Allergic Reactions
Interventions
First Posted Date
2025-02-19
Last Posted Date
2025-02-19
Lead Sponsor
ARS Pharmaceuticals, Inc.
Target Recruit Count
600
Registration Number
NCT06834165

Comparison of Bupivacaine Wound Infiltration Versus Wound Instillation to Minimize Postoperative Pain After Thyroid Surgery

Phase 3
Not yet recruiting
Conditions
Thyroid Surgery
Interventions
First Posted Date
2025-01-23
Last Posted Date
2025-01-23
Lead Sponsor
Assiut University
Target Recruit Count
102
Registration Number
NCT06789575

Pharmacokinetics Study of DESF in Adults with Oral Allergy Syndrome

Phase 2
Completed
Conditions
Allergic Reaction
Interventions
First Posted Date
2024-07-30
Last Posted Date
2024-11-05
Lead Sponsor
Aquestive Therapeutics
Target Recruit Count
36
Registration Number
NCT06527937
Locations
🇺🇸

Frontage Clinical Services, Inc., Secaucus, New Jersey, United States

Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery

Not Applicable
Not yet recruiting
Conditions
Hypotension
Spinal Block
Cesarean Section
Interventions
First Posted Date
2024-07-22
Last Posted Date
2024-07-22
Lead Sponsor
Cairo University
Target Recruit Count
212
Registration Number
NCT06512402
Locations
🇪🇬

Cairo University, Cairo, Egypt

Multimodal Orthognathic Study Comparing Use of Exparel With Standard of Care.

Early Phase 1
Completed
Conditions
Pain, Postoperative
Interventions
First Posted Date
2024-07-12
Last Posted Date
2024-07-19
Lead Sponsor
United States Naval Medical Center, San Diego
Target Recruit Count
86
Registration Number
NCT06499181
Locations
🇺🇸

Naval Medical Center San Diego, San Diego, California, United States

Early Resuscitation in Paediatric Sepsis Using Inotropes

Phase 2
Not yet recruiting
Conditions
Sepsis
Interventions
Other: Fluid
First Posted Date
2024-06-27
Last Posted Date
2024-06-27
Lead Sponsor
NATALIA LOPERA MUNERA
Target Recruit Count
40
Registration Number
NCT06478797
Locations
🇦🇷

Hospital de Niños "Dr. Orlando Alassia", Santa Fe, Argentina

🇧🇴

Hospital Regional San Juan De Dios Tarija, Tarija, Bolivia

🇵🇾

Hospital De Clínicas, Asunción, Paraguay

and more 1 locations

Bupivacaine and Epinephrine Injection Study

Phase 2
Recruiting
Conditions
Anesthesia
Sinus Disease
Bleeding
Interventions
First Posted Date
2024-06-13
Last Posted Date
2025-05-15
Lead Sponsor
Amin Javer
Target Recruit Count
80
Registration Number
NCT06456255
Locations
🇨🇦

St.Paul's Hospital Sinus Center, Vancouver, British Columbia, Canada

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges

Phase 1
Recruiting
Conditions
Anaphylaxis
Hypersensitivity
Interventions
First Posted Date
2024-06-06
Last Posted Date
2024-12-03
Lead Sponsor
Dr. George Luciuk
Target Recruit Count
60
Registration Number
NCT06445374
Locations
🇨🇦

1232176 Bc Ltd, Richmond, British Columbia, Canada

Intrathecal Dexmedetomidine vs Epinephrine

Phase 4
Recruiting
Conditions
Cesarean Section
Anesthesia, Spinal
Interventions
Drug: Standardized Spinal Mixture
First Posted Date
2024-05-17
Last Posted Date
2024-10-11
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
90
Registration Number
NCT06418308
Locations
🇺🇸

Mount Sinai Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath